🇺🇸 Benzoyl Peroxide Topical in United States
12 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 12
Most-reported reactions
- Drug Ineffective — 2 reports (16.67%)
- Product Physical Consistency Issue — 2 reports (16.67%)
- Acne — 1 report (8.33%)
- Burning Sensation — 1 report (8.33%)
- Drug Dose Omission — 1 report (8.33%)
- Expired Product Administered — 1 report (8.33%)
- Off Label Use — 1 report (8.33%)
- Paraesthesia — 1 report (8.33%)
- Product Physical Issue — 1 report (8.33%)
- Product Quality Issue — 1 report (8.33%)
Other Dermatology approved in United States
Frequently asked questions
Is Benzoyl Peroxide Topical approved in United States?
Benzoyl Peroxide Topical does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Benzoyl Peroxide Topical in United States?
University of Missouri-Columbia is the originator. The local marketing authorisation holder may differ — check the official source linked above.